Publications by authors named "Dora Menchaca"

Claim this Profile
P
Pharmacokinetics and pharmacodynamics of a novel depot formulation of abarelix, a gonadotropin-releasing hormone (GnRH) antagonist, in healthy men ages 50 to 75.
Shekman L Wong, David T-W Lau, Sharon A Baughman, Nick Fotheringham, Dora Menchaca

J Clin Pharmacol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer.
Shekman L Wong, David T-W Lau, Sharon A Baughman, Dora Menchaca, Marc B Garnick

Clin Pharmacol Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.
Michael W Schuster, Roy Beveridge, Debra Frei-Lahr, Camille N Abboud, Scott Cruickshank, Dora Menchaca

Exp Hematol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor.
Russell L Basser, Elizabeth O'Flaherty, Michael Green, Maria Edmonds, Janet Nichol, Dora M Menchaca

Blood· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis